Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT02152982 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02152982
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-15
- Primary completion
- 2021-12-01
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.